The pathophysiology of pregnancy-induced hypertension (PIH) is unknown, but appears to involve an intrinsic defect in trophoblast cell migration. The factors that regulate this migration have not been elucidated, but one such factor may be the oxygen tension which cytotrophoblast cells encounter once implantation has occurred. Cytotrophoblast cell migrate under the low oxygen tension present in decidual tissue and migration essentially ceases once a maternal arterial-placental blood supply has been established-Oxygen tension may thereby regulate cytotrophoblast cell proliferation, differentiation and the formation of proteases such as plasmin that are involved in migration and vascular remodeling. In PIH, the failure of cytotrophoblast cells to elaborate plasmin under hypoxic conditions may part of the fundamental defect in cell migration. Because the migration of cytotrophoblasts into the maternal vessels is impaired in PIH, the remodeling of maternal uterine arteries that occurs during the first trimester in uncomplicated pregnancy is incomplete. Smooth muscle cells persist in the distal portions of these vessels at term where they are found in apposition to trophoblast cells. Trophoblast cells produce thromboxanes and prostacylin and we have observed recently that they secrete big-endothelin-1 and express endothelin converting enzyme as well. Production of endothelin and thromboxanes by trophoblast cells may be stimulated by hypoxia which, in turn, may cause the incompletely remodeled uterine arteries in PIH to undergo vasoconstriction, further impairing placental blood flow. To date, essentially all studies of cultured human trophoblast cells have been performed under oxygen tensions (21% 02, 150 mmHg) well above those encountered by migrating cytotrophoblast cells in vivo (7% 02, 40-50 mmHg). Therefore, we will examine the effect of physiologic oxygen tension and hypoxia on several functions of cytotrophoblast cells that may be involved in the pathogenesis of PIH and its clinical manifestations. Specifically, we will determine whether oxygen tension: 1. regulates cytotrophoblast cell proliferation, differentiation and the production of betaHCG and prolactin; 2. coordinately regulates cytotrophoblast production of urokinase, urokinase receptors, urokinase inhibitors and the alpha2-macroglobulin receptor clearance pathway so as to enhance the production of plasmin; 3. stimulates the production of endothelin and thromboxanes at the expense of prostacyclin. The behavior of cytotrophoblast cells from patients with PIH will be compared with normal and hypoxic cells. These studies will help to elucidate the role of placental ischemia in the pathogenesis and clinical manifestations of PIH.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL050790-01
Application #
3369726
Study Section
Special Emphasis Panel (ZHL1-CSR-K (S2))
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Blank, M; Eldor, A; Tavor, S et al. (1999) A mouse model for heparin-induced thrombocytopenia. Semin Hematol 36:12-6
Cines, D B (1998) Glycoprotein IIb/IIIa antagonists: potential induction and detection of drug-dependent antiplatelet antibodies. Am Heart J 135:S152-9
Blank, M; Cines, D B; Arepally, G et al. (1997) Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin. Clin Exp Immunol 108:333-9
Zhang, L; Strickland, D K; Cines, D B et al. (1997) Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide. J Biol Chem 272:27053-7
Arepally, G; McKenzie, S E; Jiang, X M et al. (1997) Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 89:370-5
Shlansky-Goldberg, R D; Cines, D B; Sehgal, C M (1996) Catheter-delivered ultrasound potentiates in vitro thrombolysis. J Vasc Interv Radiol 7:313-20
Higazi, A A; Kniss, D; Manuppello, J et al. (1996) Thermotaxis of human trophoblastic cells. Placenta 17:683-7
Cines, D B; McCrae, K R (1995) The antiphospholipid-protein syndrome. J Clin Immunol 15:86S-100S
Arepally, G; Reynolds, C; Tomaski, A et al. (1995) Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648-54
Hasan, A A; Cines, D B; Herwald, H et al. (1995) Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem 270:19256-61